Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-13 5:01 pm Purchase | 2022-10-11 | 13G | ORGANOGENESIS HLDGS INC CLASS ORGO | Soleus Capital Master Fund, L.P. | 6,626,063 5.100% | 6,626,063 (New Position) | Filing History |
| 2022-09-28 5:01 pm Purchase | 2022-09-27 | 13G | EDAP TMS S.A. SPONS ADR FOCL | Soleus Capital Master Fund, L.P. | 4,889,745 13.400% | 1,741,136 (+55.30%) | Filing History |
| 2022-09-02 10:21 am Purchase | 2022-08-31 | 13G | SURMODICS INC SRDX | Soleus Capital Master Fund, L.P. | 713,964 5.100% | 713,964 (New Position) | Filing History |
| 2022-09-02 10:18 am Purchase | 2022-08-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Soleus Capital Master Fund, L.P. | 498,279 5.000% | 498,279 (New Position) | Filing History |
| 2022-09-01 09:00 am Purchase | 2022-08-29 | 13G | IRADIMED CORP COM IRMD | Soleus Capital Master Fund, L.P. | 646,411 5.100% | 646,411 (New Position) | Filing History |
| 2022-05-18 06:06 am Purchase | 2022-05-16 | 13G | CELCUITY INC CELC | Soleus Capital Master Fund, L.P. | 948,389 6.100% | 948,389 (New Position) | Filing History |
| 2022-04-29 5:01 pm Purchase | 2022-04-28 | 13G | CVRX INC CVRX | Soleus Capital Master Fund, L.P. | 1,044,040 5.100% | 1,044,040 (New Position) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | EDAP TMS S.A. SPONS ADR FOCL | Soleus Capital Master Fund, L.P. | 3,148,609 9.400% | 1,324,043 (+72.57%) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | THERATECHNOLOGIES INC THTX | Soleus Capital Master Fund, L.P. | 2,310,520 9.600% | 454,174 (+24.47%) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | APOLLO ENDOSURGERY INC APEN | Soleus Capital Master Fund, L.P. | 2,295,100 5.800% | 209,603 (+10.05%) | Filing History |
| 2022-01-27 4:30 pm Purchase | 2022-01-24 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund, L.P. | 48,561 5.400% | 48,561 (New Position) | Filing History |
| 2021-12-20 5:01 pm Purchase | 2021-12-14 | 13G | APOLLO ENDOSURGERY INC APEN | Soleus Capital Master Fund, L.P. | 2,085,497 5.300% | 2,085,497 (New Position) | Filing History |